Bolivia vs Suriname: Access to anti-retroviral drugs, female (%)
Bolivia
62.0%
in 2024
Suriname
62.0%
in 2024
Bolivia rank
99th
Suriname rank
99th
Access to anti-retroviral drugs, female (%) over time
- Bolivia
- Suriname
How they compare
Bolivia currently reports 62.0% against 62.0% in Suriname, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Suriname ahead.
Bolivia ranks 99th and Suriname ranks 99th of 141 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 9.0% | 6.9% | Suriname |
| 2010s | 29.4% | 43.9% | 14.5% | Suriname |
| 2020s | 57.6% | 58.8% | 1.2% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bolivia or Suriname?
- Bolivia, at 62.0% against 62.0% in Suriname as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bolivia and Suriname?
- 0.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Suriname?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia and Suriname rank globally for access to anti-retroviral drugs, female?
- Bolivia ranks 99th and Suriname ranks 99th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.